We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

157 hedge funds and large institutions have $439M invested in BioDelivery Sciences International, Inc. in 2019 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 10

100% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 29

71% more capital invested

Capital invested by funds: $256M → $439M (+$182M)

32% more funds holding

Funds holding: 119157 (+38)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

37% less call options, than puts

Call options by funds: $461K | Put options by funds: $737K

Holders
157
Holders Change
+38
Holders Change %
+31.93%
% of All Funds
3.09%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
48
Increased
58
Reduced
29
Closed
10
Calls
$461K
Puts
$737K
Net Calls
-$276K
Net Calls Change
-$596K
Name Holding Trade Value Shares
Change
Change in
Stake
William Blair & Company
26
William Blair & Company
Illinois
$5.84M +$161K +27,410 +3%
1CM
27
1492 Capital Management
Wisconsin
$5.22M +$277K +47,199 +6%
Marshall Wace
28
Marshall Wace
United Kingdom
$5.05M +$4.7M +798,872 New
EI
29
EAM Investors
California
$4.14M +$3.17M +539,742 +470%
Squarepoint
30
Squarepoint
New York
$3.29M +$46.6K +7,934 +2%
MSL
31
Mackay Shields LLC
New York
$3.25M -$534K -90,900 -15%
Charles Schwab
32
Charles Schwab
California
$3.25M -$36.5K -6,206 -1%
DMK
33
David M. Knott
$3.19M -$75.8K -12,900 -2%
MAM
34
Martingale Asset Management
Massachusetts
$3M +$1.31M +223,066 +89%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.89M +$1.42M +241,205 +112%
Millennium Management
36
Millennium Management
New York
$2.75M +$2.31M +393,351 +943%
CAM
37
ClariVest Asset Management
California
$2.57M -$311K -52,900 -12%
PAM
38
Panagora Asset Management
Massachusetts
$2.49M +$2.31M +393,609 New
WG
39
Winton Group
United Kingdom
$2.47M +$192K +32,594 +9%
Assenagon Asset Management
40
Assenagon Asset Management
Luxembourg
$2.46M +$2.29M +388,818 New
Invesco
41
Invesco
Georgia
$2.44M +$2.27M +385,670 New
EIM
42
Essex Investment Management
Massachusetts
$2.38M +$104K +17,718 +5%
PPA
43
Parametric Portfolio Associates
Washington
$2.16M +$1.58M +268,672 +370%
EP
44
Eversept Partners
New York
$2.12M -$2.19M -372,535 -53%
EGM
45
Engineers Gate Manager
New York
$2.04M +$1.9M +322,779 New
EGI
46
EAM Global Investors
California
$1.83M +$1.7M +289,762 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.77M -$78.7K -13,397 -5%
PCM
48
Penn Capital Management
Pennsylvania
$1.74M -$2.84M -483,517 -64%
ARTA
49
A.R.T. Advisors
New York
$1.57M +$1.32M +224,300 +928%
Bessemer Group
50
Bessemer Group
New Jersey
$1.56M +$547K +93,100 +60%

BDSI Hedge Fund Activity: Q4 2019 in Review

157 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2019, worth a combined $439M — up 71% from $256M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new BDSI positions and 10 closed out — a net gain of 38 holders — while 58 added to existing stakes and 29 trimmed.

The largest buyer was Systematic Financial Management, adding an estimated $10.6M. The largest seller was Avoro Capital Advisors, cutting an estimated $26M.

  • 157 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2019, up from 119 in Q3 2019.
  • Funds reported $439M of BioDelivery Sciences International, Inc. stock for Q4 2019, up 71% quarter-over-quarter.
  • 48 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2019 and 10 closed out, a net change of +38 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2019 was Systematic Financial Management, an estimated $10.6M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2019 was Avoro Capital Advisors, an estimated $26M sold.

Based on aggregated 13F filings for Q4 2019.